ENTPD1 and lip and oral cavity carcinoma: Nevertheless, the therapeutic potential of pyrimidines in the TME has not been widely explored. A comprehensive understanding of the crosstalk between CD39 and pyrimidine metabolism, especially the role of enriched uracil in the prognosis of oral cancer, is crucial for the identification of strategies to improve the patient outcomes.